Geneva, July 7 -- International Clinical Trials Registry received information related to the study (NCT07656792) titled 'A Study in Japanese Healthy Men to Test How Well Different Doses of BI 3031185 Are Tolerated and a Study in Japanese Healthy Women to Test Whether BI 3031185 Influences the Amount of a Contraceptive in the Blood' on June 15.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Participant).

Primary Sponsor: Boehringer Ingelheim

Condition: Healthy

Intervention: Drug: BI 3031185 Drug: Placebo matching BI 3031185 Drug: Midazolam

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: July 15, 2...